First commercial source of on-demand GMP CD34+ hematopoietic stem cells for clinical manufacturing in the industry. OrganaBio leveraging years of in-house tissue sourcing and cell isolation experience to produce high-quality GMP-compliant cells.

The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.

Highly sensitive and multiplexed assay for the detection, discrimination, and quantification of key mutations in ESR1 gene for breast cancer, developed for bio-Rad’s QX600™ droplet digital™ PCR system.

Arrayjet’s patented spot-on-spot microarray screening technology is available for customers to adopt in-house and via Arrayjet’s CRO/CMO services.

Erasmus University Medical Center uses ENPICOM’s IGX Platform and services to advance their research on identifying cancer nanobodies.

High accuracy and detection to identify tumor variants from degraded and low input samples as well as samples with limited DNA abundance. Library preparation kit adds to Twist’s portfolio of tools to enable liquid biopsy applications

Cancer Research UK and Stitch are pleased to announce the expansion of their partnership, focused on enhancing the patient experience within clinical trials.

AMSBIO has launched a new 2024 travel grant award scheme for scientists under the age of thirty, employed in academia, research institutions, or companies engaged in cancer and stem cell research.

In an informative new blog post - AMSBIO reflects on a selection of the groundbreaking life science and biomedical research undertaken by its customers during 2023.

InSphero, and ATCC, will work together to introduce new paradigms in the rapidly evolving field of 3D cell-based oncology research.